← Back to Clinical Trials
Recruiting NCT04141202

NCT04141202 Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04141202
Status Recruiting
Phase
Sponsor St. Olavs Hospital
Condition Substance-Related Disorders
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2020-02-25
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2020-02-25 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In 2017, structured physical exercise with high intensity was implemented as a part of the treatment program at St. Olav Hospital Clinic of Substance Use and Addiction Medicine. The objective of this study is to examine whether implementing structured physical exercise in the treatment program has implications for patients' physical and mental health and quality of life after completing a 3 month residential treatment program. The results of this study will benefit substance use disorder patients in the future, and may have an impact on further implementation of physical exercise in addiction treatment clinics both nationally and internationally.

Eligibility Criteria

Inclusion Criteria: * Being an inpatient at the clinic Exclusion Criteria: \-

Contact & Investigator

Central Contact

Grete Flemmen, phd

✉ grete.flemmen@stolav.no

📞 +47 908 77 876

Principal Investigator

Kristin Smedsrud

STUDY DIRECTOR

St Olavs Hospital Klinikk for rus- og avhengighetsmedisin

Frequently Asked Questions

Who can join the NCT04141202 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Substance-Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04141202 currently recruiting?

Yes, NCT04141202 is actively recruiting participants. Contact the research team at grete.flemmen@stolav.no for enrollment information.

Where is the NCT04141202 trial being conducted?

This trial is being conducted at Trondheim, Norway.

Who is sponsoring the NCT04141202 clinical trial?

NCT04141202 is sponsored by St. Olavs Hospital. The principal investigator is Kristin Smedsrud at St Olavs Hospital Klinikk for rus- og avhengighetsmedisin. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology